Species: Neisseriaceae [G1] bacterium HMT-327 (HMT-0327) Primary Body Site: Nasal
Download Options
LINKS: Ecology Home
| HMT-0327: [Body Sites Data]
[Taxon Description]
| Life Page: Neisseriaceae [G1] bacterium HMT-327
Hide Legend
Prev - Prevalence
10thp - 10th percentile
90thp - 90th percentile
ND - less than 0.001%
Body Site Legend:
| SUBP-- Subgingival Plaque |
| SUPP -- Supragingival Plaque |
| PERIO -- Periodontal |
| AKE -- Attached Keratinized Gingiva |
| BMU -- Buccal Mucosa |
| HPA -- Hard Palate |
| SAL -- Saliva |
| THR -- Throat |
| PTO -- Palatine Tonsils |
| TDO -- Tongue Dorsum |
| ANA -- Anterior Nares |
| LRC -- L_Retroauricular Crease |
| RRC -- R_Retroauricular Crease |
| LAF -- L_Antecubital Fossa |
| RAF -- R_Antecubital Fossa |
| VIN -- Vaginal Introitus |
| MVA -- Mid Vagina |
| PFO -- Posterior Fornix |
| STO -- Stool |
Prev - Prevalence
10thp - 10th percentile
90thp - 90th percentile
ND - less than 0.001%
Human Microbiome Project Mapping (Data from healthy subjects. - not published)
No Notes
Eren V1-V3 www.pnas.org
(Data from healthy subjects.)
No Notes
Eren V3-V5 www.pnas.org
(Data from healthy subjects.)
No Notes
Human Microbiome Project 16S RefSeq (V1-V3) (Data from healthy subjects. - not published)
No Notes
| SUBP | SUPP | AKE | BMU | HPA | SAL | THR | PTO | TDO | ANA | LRC | RRC | LAF | RAF | VIN | MVA | PFO | STO | |
| Avg (%) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0.28 | 0.21 | 0.47 | 0.10 | 0.17 | 0 | 0 | 0 | 0 |
| n | NaN | NaN | NaN | NaN | NaN | NaN | NaN | NaN | NaN | NaN | NaN | NaN | NaN | NaN | NaN | NaN | NaN | NaN |
| 10thp | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| 90thp | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0.44 | 0.01 | 0.01 | 0.03 | 0.03 | 0 | 0 | 0 | 0 |
| Stdev | 0 | 0 | 0 | 0 | 0 | 0 | 0.03 | 0 | 0 | 1.11 | 1.65 | 3.77 | 0.64 | 1.02 | 0 | 0 | 0 | 0 |
| Prev(%) | 0 | 0 | 0 | 0 | 0 | 0 | 0.59 | 0 | 0 | 19.67 | 11.78 | 12.18 | 11.49 | 11.52 | 0 | 0 | 0 | 0 |
Human Microbiome Project 16S RefSeq (V3-V5) (Data from healthy subjects. - not published)
No Notes
| SUBP | SUPP | AKE | BMU | HPA | SAL | THR | PTO | TDO | ANA | LRC | RRC | LAF | RAF | VIN | MVA | PFO | STO | |
| Avg (%) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0.49 | 0.49 | 0.77 | 0.30 | 0.28 | 0 | 0 | 0 | 0 |
| n | NaN | NaN | NaN | NaN | NaN | NaN | NaN | NaN | NaN | NaN | NaN | NaN | NaN | NaN | NaN | NaN | NaN | NaN |
| 10thp | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| 90thp | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0.89 | 0.01 | 0.04 | 0 | 0 | 0 | 0 | 0 | 0 |
| Stdev | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1.97 | 3.81 | 5.62 | 1.90 | 1.83 | 0 | 0 | 0 | 0 |
| Prev(%) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 21.46 | 10.51 | 13.27 | 9.65 | 8.00 | 0 | 0 | 0 | 0 |
Dewhirst 35x9 (35 Taxa by 9 Oral Sites. - not published)
No Notes
| SUBP | SUPP | AKE | BMU | HPA | SAL | THR | PTO | TDO | ANA | |
| Avg (%) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0.21 |
| n | NaN | NaN | NaN | NaN | NaN | NaN | NaN | NaN | NaN | NaN |
| 10thp | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| 90thp | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0.36 |
| Stdev | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0.64 |
| Prev(%) | 0 | 0 | 0 | 0 | 0 | 4.00 | 0 | 0 | 0 | 20.00 |
Human Microbiome Project Metaphlan (Data from healthy subjects. - not published)
No Notes
